These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4435022)

  • 1. Dopamine turnover in the rat corpus striatum: in vivo and in vitro studies on the action of amantadine.
    Vaatstra WJ; Eigeman L
    Eur J Pharmacol; 1974 Feb; 25(2):185-90. PubMed ID: 4435022
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of amantadine on the rate of dopamine synthesis in rat corpus striatum.
    Bariletto S; Dollar E; Leitz F
    J Neurochem; 1975 Aug; 25(2):139-42. PubMed ID: 1141911
    [No Abstract]   [Full Text] [Related]  

  • 3. Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.
    Von Voigtlander PF; Moore KE
    Neuropharmacology; 1973 May; 12(5):451-62. PubMed ID: 4145343
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of catechol-O-methyl transferase inhibitors on behavior and dopamine metabolism.
    McKenzie GM
    Adv Biochem Psychopharmacol; 1974; 12(0):339-51. PubMed ID: 4419524
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3',5;-adenosine monophosphate concentrations of rat striatum.
    Gerhards HJ; Carenzi A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(1):49-63. PubMed ID: 4375258
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
    [No Abstract]   [Full Text] [Related]  

  • 7. Amantadine and apomorphine: interactions on striatal dopamine receptors.
    Cox B
    Proc West Pharmacol Soc; 1975; 18():162-7. PubMed ID: 1237137
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors.
    Cox B; Kastin AJ; Schnieden H
    Eur J Pharmacol; 1976 Mar; 36(1):141-7. PubMed ID: 4332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine hydroxylation in the rat striatum in vitro and in vivo after nigral lesion and chlorpromazine treatment.
    Fyrö B; Nybäck H; Sedvall G
    Neuropharmacology; 1972 Jul; 11(4):531-7. PubMed ID: 4403078
    [No Abstract]   [Full Text] [Related]  

  • 10. Action of opiates, antipsychotics, amphetamine and apomorphine on dopamine receptors in rat striatum: in vivo changes of 3',5'-cyclic AMP content and acetylcholine turnover rate.
    Carenzi A; Cheney DL; Costa E; Guidotti A; Racagni G
    Neuropharmacology; 1975 Dec; 14(12):927-39. PubMed ID: 3748
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of apomorphine, amantadine and dimethylaminoadamantane on the level of cyclic AMP in the rat striatum.
    Janiec W; Piekarska T; Szczypior M; Misterkiewicz E
    Pol J Pharmacol Pharm; 1977; 29(2):93-9. PubMed ID: 193093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of several dopaminergic drugs and trihexyphenidyl on cholinergic parameters in the rat striatum.
    Consolo S; Ladinsky H; Garattini S
    J Pharm Pharmacol; 1974 Apr; 26(4):275-7. PubMed ID: 4151386
    [No Abstract]   [Full Text] [Related]  

  • 13. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
    Allen RM; Lane JD; Brauchi JT
    Eur J Pharmacol; 1980 Jul; 65(2-3):313-5. PubMed ID: 7190503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of amantadine as a releasing agent or uptake blocker for H 3 -dopamine in rat brain slices.
    Heikkila RE; Cohen G
    Eur J Pharmacol; 1972 Nov; 20(2):156-60. PubMed ID: 4651205
    [No Abstract]   [Full Text] [Related]  

  • 15. Compartmentation of dopamine in rat striatum.
    Doteuchi M; Wang C; Costa E
    Mol Pharmacol; 1974 Mar; 10(2):225-34. PubMed ID: 4152816
    [No Abstract]   [Full Text] [Related]  

  • 16. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of drugs stimulating dopaminergic system on phosphodiesterase activity in rat striatum.
    Janiec W; Piekarska T; Szczypior M; Misterkiewicz E
    Pol J Pharmacol Pharm; 1976; 28(6):631-4. PubMed ID: 189292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM
    Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity of dopamine transmission in the rat striatum after treatment with the NMDA receptor antagonist amantadine.
    Peeters M; Page G; Maloteaux JM; Hermans E
    Brain Res; 2002 Sep; 949(1-2):32-41. PubMed ID: 12213297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined effect of amphetamine and midantan on the dopaminergic transmission in the striatum of freely moving rats].
    Afanas'ev II; Dvorkina ML; Raevskiĭ KS
    Eksp Klin Farmakol; 2003; 66(1):3-7. PubMed ID: 12683071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.